BIOMAT Database Logo BIOMAT Database Logo

High-grade transformation in nodular lymphocyte predominant Hodgkin lymphoma. 2020

Sonali Susmita Nayak, and Sangeetha K Parthiban, and Peter Paul, and Sumeet Gujral
Department of Pathology, Homi Bhabha Cancer Hospital and Research Center, Visakhapatnam, Andhra Pradesh, India.

UI MeSH Term Description Entries
D008198 Lymph Nodes They are oval or bean shaped bodies (1 - 30 mm in diameter) located along the lymphatic system. Lymph Node,Node, Lymph,Nodes, Lymph
D008297 Male Males
D010984 Platinum A heavy, soft, whitish metal, resembling tin, with atomic number 78, atomic weight 195.084, symbol Pt. It is used in manufacturing equipment for laboratory and industrial use. It occurs as a black powder (platinum black) and as a spongy substance (spongy platinum) and may have been known in Pliny's time as "alutiae". Platinum Black
D003841 Deoxycytidine A nucleoside component of DNA composed of CYTOSINE and DEOXYRIBOSE. Cytosine Deoxyribonucleoside,Cytosine Deoxyriboside,Deoxyribonucleoside, Cytosine,Deoxyriboside, Cytosine
D003907 Dexamethasone An anti-inflammatory 9-fluoro-glucocorticoid. Hexadecadrol,Decaject,Decaject-L.A.,Decameth,Decaspray,Dexasone,Dexpak,Hexadrol,Maxidex,Methylfluorprednisolone,Millicorten,Oradexon,Decaject L.A.
D006689 Hodgkin Disease A malignant disease characterized by progressive enlargement of the lymph nodes, spleen, and general lymphoid tissue. In the classical variant, giant usually multinucleate Hodgkin's and REED-STERNBERG CELLS are present; in the nodular lymphocyte predominant variant, lymphocytic and histiocytic cells are seen. Granuloma, Hodgkin,Granuloma, Malignant,Hodgkin Lymphoma,Lymphogranuloma, Malignant,Granuloma, Hodgkin's,Granuloma, Hodgkins,Hodgkin Lymphoma, Adult,Hodgkin's Disease,Hodgkin's Lymphoma,Hodgkins Disease,Lymphocyte Depletion Hodgkin's Lymphoma,Lymphocyte-Rich Classical Hodgkin's Lymphoma,Mixed Cellularity Hodgkin's Lymphoma,Nodular Lymphocyte-Predominant Hodgkin's Lymphoma,Nodular Sclerosing Hodgkin's Lymphoma,Adult Hodgkin Lymphoma,Disease, Hodgkin,Disease, Hodgkin's,Disease, Hodgkins,Hodgkin Granuloma,Hodgkin's Granuloma,Hodgkins Granuloma,Hodgkins Lymphoma,Lymphocyte Rich Classical Hodgkin's Lymphoma,Lymphogranulomas, Malignant,Lymphoma, Hodgkin,Lymphoma, Hodgkin's,Malignant Granuloma,Malignant Granulomas,Malignant Lymphogranuloma,Malignant Lymphogranulomas,Nodular Lymphocyte Predominant Hodgkin's Lymphoma
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000069283 Rituximab A murine-derived monoclonal antibody and ANTINEOPLASTIC AGENT that binds specifically to the CD20 ANTIGEN and is used in the treatment of LEUKEMIA; LYMPHOMA and RHEUMATOID ARTHRITIS. CD20 Antibody, Rituximab,GP2013,IDEC-C2B8,IDEC-C2B8 Antibody,Mabthera,Rituxan,IDEC C2B8,IDEC C2B8 Antibody,Rituximab CD20 Antibody
D000093542 Gemcitabine A deoxycytidine antimetabolite used as an antineoplastic agent. 2',2'-Difluoro-2'-Deoxycytidine,2',2'-Difluorodeoxycytidine,2'-Deoxy-2',2''-Difluorocytidine-5'-O-Monophosphate,2'-Deoxy-2'-Difluorocytidine,Gemcitabine Hydrochloride,Gemcitabine, (D-threo-pentafuranosyl)-Isomer,Gemcitabine, (alpha-D-threo-pentofuranosyl)-Isomer,Gemcitabine, (beta-D-threo-pentafuranosyl)-Isomer,Gemicitabine,2',2'-DFDC,Gemzar,LY 188011,LY-188011,dFdCyd,188011, LY,2' Deoxy 2' Difluorocytidine,2' Deoxy 2',2'' Difluorocytidine 5' O Monophosphate,Hydrochloride, Gemcitabine
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

Sonali Susmita Nayak, and Sangeetha K Parthiban, and Peter Paul, and Sumeet Gujral
Nodular lymphocyte-predominant hodgkin lymphoma.
July 2007, Seminars in radiation oncology,
Sonali Susmita Nayak, and Sangeetha K Parthiban, and Peter Paul, and Sumeet Gujral
[Nodular lymphocyte predominant Hodgkin lymphoma].
July 2005, Zhonghua bing li xue za zhi = Chinese journal of pathology,
Sonali Susmita Nayak, and Sangeetha K Parthiban, and Peter Paul, and Sumeet Gujral
Nodular lymphocyte-predominant Hodgkin lymphoma.
July 2016, Seminars in hematology,
Sonali Susmita Nayak, and Sangeetha K Parthiban, and Peter Paul, and Sumeet Gujral
Nodular lymphocyte-predominant Hodgkin lymphoma.
July 2008, Current hematologic malignancy reports,
Sonali Susmita Nayak, and Sangeetha K Parthiban, and Peter Paul, and Sumeet Gujral
Nodular lymphocyte predominant Hodgkin lymphoma.
July 2009, The oncologist,
Sonali Susmita Nayak, and Sangeetha K Parthiban, and Peter Paul, and Sumeet Gujral
High familial risk in nodular lymphocyte-predominant Hodgkin lymphoma.
March 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology,
Sonali Susmita Nayak, and Sangeetha K Parthiban, and Peter Paul, and Sumeet Gujral
Nodular Lymphocyte-Predominant Hodgkin Lymphoma in Progressive Transformation of Germinal Centers.
January 2017, Case reports in otolaryngology,
Sonali Susmita Nayak, and Sangeetha K Parthiban, and Peter Paul, and Sumeet Gujral
Evolutionary clonal trajectories in nodular lymphocyte-predominant Hodgkin lymphoma with high risk of transformation.
October 2021, Haematologica,
Sonali Susmita Nayak, and Sangeetha K Parthiban, and Peter Paul, and Sumeet Gujral
Nodular lymphocyte predominant Hodgkin lymphoma in siblings.
March 2004, Leukemia & lymphoma,
Sonali Susmita Nayak, and Sangeetha K Parthiban, and Peter Paul, and Sumeet Gujral
Variant histology nodular lymphocyte predominant Hodgkin lymphoma - a route to transformation?
May 2018, British journal of haematology,
Copied contents to your clipboard!